EP2362909A4 - INFECTIONS INVOLVED MIRACLE GENES - Google Patents

INFECTIONS INVOLVED MIRACLE GENES

Info

Publication number
EP2362909A4
EP2362909A4 EP09818408A EP09818408A EP2362909A4 EP 2362909 A4 EP2362909 A4 EP 2362909A4 EP 09818408 A EP09818408 A EP 09818408A EP 09818408 A EP09818408 A EP 09818408A EP 2362909 A4 EP2362909 A4 EP 2362909A4
Authority
EP
European Patent Office
Prior art keywords
miracle
genes
infections
infections involved
involved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09818408A
Other languages
German (de)
French (fr)
Other versions
EP2362909A2 (en
Inventor
Donald Rubin
Thomas Hodge
James Murray
Natalie Mcdonald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zirus Inc
Vanderbilt University
Original Assignee
Zirus Inc
Vanderbilt University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zirus Inc, Vanderbilt University filed Critical Zirus Inc
Publication of EP2362909A2 publication Critical patent/EP2362909A2/en
Publication of EP2362909A4 publication Critical patent/EP2362909A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y601/00Ligases forming carbon-oxygen bonds (6.1)
    • C12Y601/01Ligases forming aminoacyl-tRNA and related compounds (6.1.1)
    • C12Y601/01005Isoleucine-tRNA ligase (6.1.1.5)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering nucleic acids [NA]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00Production
    • C12N2330/30Production chemically synthesised
    • C12N2330/31Libraries, arrays
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP09818408A 2008-09-30 2009-09-30 INFECTIONS INVOLVED MIRACLE GENES Withdrawn EP2362909A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19477408P 2008-09-30 2008-09-30
US19577008P 2008-10-09 2008-10-09
PCT/US2009/058947 WO2010039778A2 (en) 2008-09-30 2009-09-30 Mammalian genes involved in infection

Publications (2)

Publication Number Publication Date
EP2362909A2 EP2362909A2 (en) 2011-09-07
EP2362909A4 true EP2362909A4 (en) 2012-10-10

Family

ID=42074170

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09818408A Withdrawn EP2362909A4 (en) 2008-09-30 2009-09-30 INFECTIONS INVOLVED MIRACLE GENES

Country Status (2)

Country Link
EP (1) EP2362909A4 (en)
WO (1) WO2010039778A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2611195C2 (en) * 2010-10-27 2017-02-21 Курна, Инк. Treatment of interferon-related developmental regulator 1 (ifrd1) associated diseases by inhibition of natural antisense transcript to ifrd1
WO2013110120A1 (en) * 2012-01-24 2013-08-01 Inter-K Pty Limited Peptide agents for cancer therapy
FR2987627B1 (en) * 2012-03-05 2016-03-18 Splicos USE OF RBM39 AS A BIOMARKER
EP2866829B1 (en) * 2012-07-02 2017-12-06 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Paramyxovirus and methods of use
EP3572513B1 (en) * 2013-12-09 2025-09-24 Baylor College of Medicine Hippo and dystrophin complex signaling in cardiomyocyte renewal
WO2019119036A1 (en) * 2017-12-19 2019-06-27 Benitec Biopharma Limited Cd70 deficient cells, and methods and reagents for producing same
CN108707607A (en) * 2018-06-08 2018-10-26 邵玉芹 A kind of aptamers and kit of energy specific detection EV71 viruses
JP7271727B2 (en) * 2019-05-29 2023-05-11 セントレ ナショナル デ ラ レセルシュ シャンティフィク Methods for identifying ubiquitin and ubiquitin-like enzymatic activities
CN113274510B (en) * 2021-04-29 2022-05-13 山东农业大学 Composition for inhibiting J subgroup avian leukosis virus replication and application thereof
JP2025540101A (en) * 2022-12-01 2025-12-11 キャンプ4 セラピューティクス コーポレイション Modulation of SYNGAP1 gene transcription using antisense oligonucleotides targeting regulatory RNAs
CN118576714B (en) * 2024-05-27 2025-08-26 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) Application of HERC4 gene or protein as a target in screening drugs that inhibit foot-and-mouth disease virus replication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018505A1 (en) * 2001-06-29 2004-01-29 Lee Ernestine A. Aminoacyl trna synthetases
US20060079474A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Analogs of tRNA synthetase fragments and uses thereof
US8247451B2 (en) * 2006-01-13 2012-08-21 Vanderbilt University ADAM10 and its uses related to infection

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CLAYTON F ET AL: "Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathy.", THE AMERICAN JOURNAL OF PATHOLOGY, vol. 159, no. 5, November 2001 (2001-11-01), pages 1933 - 1939, XP002682331, ISSN: 0002-9440 *
D. MCDONALD: "Visualization of the intracellular behavior of HIV in living cells", THE JOURNAL OF CELL BIOLOGY, vol. 159, no. 3, 11 November 2002 (2002-11-11), pages 441 - 452, XP055036240, ISSN: 0021-9525, DOI: 10.1083/jcb.200203150 *
KENNEY SHANNON: "Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumors.", TRANSACTIONS OF THE AMERICAN CLINICAL AND CLIMATOLOGICAL ASSOCIATION, vol. 117, 2006, pages 55 - 74, XP002682332, ISSN: 0065-7778 *
W. ZHANG ET AL: "RNA Interference Inhibits Respiratory Syncytial Virus Replication and Disease Pathogenesis without Inhibiting Priming of the Memory Immune Response", JOURNAL OF VIROLOGY, vol. 82, no. 24, 25 September 2008 (2008-09-25), pages 12221 - 12231, XP055036354, ISSN: 0022-538X, DOI: 10.1128/JVI.01557-08 *

Also Published As

Publication number Publication date
WO2010039778A3 (en) 2010-09-16
WO2010039778A2 (en) 2010-04-08
EP2362909A2 (en) 2011-09-07

Similar Documents

Publication Publication Date Title
FIC20240020I1 (en) Atezolizumab
FIC20250007I1 (en) Fidanacogenyalparvoweek
FIC20190008I1 (en) Abemasiclib
EP2362909A4 (en) INFECTIONS INVOLVED MIRACLE GENES
BRPI0907376A8 (en) photobioreactor
EP3988147C0 (en) INTRODUCTION ORDER
EP2335741A4 (en) INSULATOR
PT2813570T (en) SUMMARY
DK2424571T3 (en) Gene Vector
PT3045471T (en) SUMMARY
EP2320913A4 (en) NUKLEINSÄUREAPTAMERE
FI20085260A0 (en) Hearth
DK2335031T3 (en) IN-LINE-GAUGE
EP2368115A4 (en) ANALYTNACHWEISTEST
EP2350385A4 (en) FORM FIELD
DK2271613T3 (en) Hydroxymethylcyclohexylamines
DE602009000488D1 (en) Obstvereinzelvorrichtung
BRPI0907863A2 (en) pyrrolopyrimidinecarboxamides
ITVA20080004A1 (en) RHEOLOGY MODIFIER
DK2254963T3 (en) CORE-TO-FLOW IMPROVES
FR2927888B1 (en) >
DK2774612T3 (en) 4-Methylpyrazole formulations
DE602009001190D1 (en) Gleichstromumrichtervorrichtung
IT1391976B1 (en) PERFECT WHEEL STRUCTURE
ITTO20080468A1 (en) CONVECTOR

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110502

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 48/00 20060101ALI20120828BHEP

Ipc: A61K 31/00 20060101ALI20120828BHEP

Ipc: C12N 15/113 20100101AFI20120828BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20120911

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 48/00 20060101ALI20120904BHEP

Ipc: C12N 15/113 20100101AFI20120904BHEP

Ipc: A61K 31/00 20060101ALI20120904BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130403